Mutual Fund Details

HDFC Pharma And Healthcare Fund Direct - Growth

Equity Pharma

NAV

₹16.3100

as on 28 Nov 2024, 11:20 PM

₹-0.0850(0.52%)

Last Change

Investment Performance

would have given a return of

₹1,03,499

₹1,06,749

₹1,51,019

₹1,52,916

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹52,916

Profit (absolute return)

52.92%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

3.58%

In the last 6 months

27.11%

In the last 1 year

52.92%

In the last 3 years

In the last 5 years

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

HDFC Pharma And Healthcare Fund Direct - Growth

as of 31 Oct 2024, 05:30 AM

₹1,382.60 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 1%, if redeemed within 30 days.

0.93%

Expense Ratio

Plan

Growth

0.77%

Cash Holding

Benchmark

BSE Healthcare Index

Scheme Document

View

Benchmark

BSE Healthcare Index

Exit Load

Exit load of 1%, if redeemed within 30 days.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Sector

Healthcare

97.57%

₹1,349.00 Cr

Services

1.66%

₹22.95 Cr

Others

0.77%

₹10.65 Cr

Sectors Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Sector

Healthcare

97.57%

₹1,349.00 Cr

Services

1.66%

₹22.95 Cr

Others

0.77%

₹10.65 Cr

Companies Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

12.55%

₹173.52 Cr

Cipla Ltd.

6.40%

₹88.49 Cr

Lupin Ltd.

5.44%

₹75.21 Cr

Dr. Reddy's Laboratories Ltd.

5.30%

₹73.28 Cr

Gland Pharma Ltd.

4.84%

₹66.92 Cr

Others

65.47%

₹905.19 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Oct 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

12.55%

₹173.52 Cr

Cipla Ltd.

6.40%

₹88.49 Cr

Lupin Ltd.

5.44%

₹75.21 Cr

Dr. Reddy's Laboratories Ltd.

5.30%

₹73.28 Cr

Gland Pharma Ltd.

4.84%

₹66.92 Cr

Others

65.47%

₹905.19 Cr

View All

Funds in this Category

This fund's returns:

52.92%

Return Duration

1 Year

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

DSP Healthcare Fund Direct - Growth

LIC MF Healthcare Fund Direct - Growth

About HDFC Pharma And Healthcare Fund Direct - Growth

HDFC Pharma And Healthcare Fund Direct - Growth is a Equity mutual fund scheme from HDFC Mutual Fund. This scheme was launched on Invalid date. It has an AUM of ₹1,382.60 Crores and the latest NAV decalared is ₹16.310 as on 29 Nov 2024 at 10:18 am.

HDFC Pharma And Healthcare Fund Direct - Growth scheme return performance in last 1 year is 52.92%, is 63.84% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.